Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma

A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Jennifer M., Odanovic, Natalija, Arbune, Amit, Higgins, Angela, Henry, Mariana, Greif, Daniel, Foss, Francine, Baldassarre, Lauren A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311348/
https://www.ncbi.nlm.nih.gov/pubmed/34317676
http://dx.doi.org/10.1016/j.jaccas.2021.04.001
Descripción
Sumario:A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (Level of Difficulty: Advanced.)

Ejemplares similares